Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients
出版年份 2013 全文链接
标题
Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients
作者
关键词
-
出版物
Drug Metabolism and Pharmacokinetics
Volume 28, Issue 4, Pages 321-331
出版商
Japanese Society for the Study of Xenobiotics
发表日期
2013-01-22
DOI
10.2133/dmpk.dmpk-12-rg-109
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation
- (2012) Takahiko Tanigawa et al. Drug Metabolism and Pharmacokinetics
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. CIRCULATION
- Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation
- (2011) Hirotsugu Atarashi et al. CIRCULATION JOURNAL
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
- (2010) AMERICAN HEART JOURNAL
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
- (2010) Jean-Luc Martinoli et al. THROMBOSIS AND HAEMOSTASIS
- Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects
- (2009) Xia Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery
- (2009) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy in Atrial Fibrillation
- (2008) Daniel E. Singer et al. CHEST
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry
- (2008) G. Rohde JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search